Survival of Left-to-Right Shunt Repair in Children with Pulmonary Arterial Hypertension at a Tertiary Hospital in a Low-to-Middle-Income Country
References
- Ivy DD, Abman SH, Barst RJ, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 SUPPL.). DOI: 10.1016/j.jacc.2013.10.028
- Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension. Circulation. 2015; (132): 2037–2099. DOI: 10.1161/CIR.0000000000000329
- Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation. 2012; 125(1): 113–22. DOI: 10.1161/CIRCULATIONAHA.111.026591
- Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: Updates on definition, classification, diagnostics and management. Eur Respir J [Internet]. 2019; 53(1). DOI: 10.1183/13993003.01916-2018
- Kozlik-Feldmann R, Hansmann G, Bonnet D, Schranz D, Apitz C, Michel-Behnke I. Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016; 102: ii42–8. DOI: 10.1136/heartjnl-2015-308378
- Van Der Feen DE, Bartelds B, De Boer RA, Berger RMF. Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease. Heart. 2019; 105(4): 276–82. DOI: 10.1136/heartjnl-2018-314025
- Mocumbi AO, Lameira E, Yaksh A, Paul L, Ferreira MB, Sidi D. Challenges on the management of congenital heart disease in developing countries. Int J Cardiol [Internet]. 2011; 148(3): 285–8. DOI: 10.1016/j.ijcard.2009.11.006
- Alonso-Gonzalez R, Lopez-Guarch CJ, Subirana-Domenech MT, et al. Pulmonary hypertension and congenital heart disease: An insight from the REHAP national registry. Int J Cardiol [Internet]. 2015; 184(1): 717–23. DOI: 10.1016/j.ijcard.2015.02.031
- Saxena A, Ramakrishnan S, Tandon R, et al. Consensus on timing of intervention for common congenital heart diseases. Indian Pediatr. 2008; 45: 117–26.
- Talwar S, Keshri VK, Choudhary SK, et al. Surgical strategies for patients with congenital heart disease and severe pulmonary hypertension in low/middle-income countries. Heart Asia. 2015; 7(2): 31–317.
- Myers PO, Tissot C, Beghetti M. Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease – Do we have the good tools to predict success? Circ J. 2014; 78(1): 4–11. DOI: 10.1253/circj.CJ-13-1263
- Berger RMF, Beghetti M, Humpl T, et al. Clinical features of paediatric pulmonary hypertension: A registry study. Lancet [Internet]. 2012; 379(9815): 537–46. DOI: 10.1016/S0140-6736(11)61621-8
- Zuckerman WA, Krishnan U, Rosenzweig EB. Pulmonary arterial hypertension associated with congenital heart disease. Curr Pediatr Rep. 2013; 1(2): 92–101. DOI: 10.1007/s40124-013-0015-7
- Murni IK, Djer MM, Yanuarso PB, et al. Outcome of pediatric cardiac surgery and predictors of major complication in a developing country. Ann Pediatr Cardiol. 2019; 12(1): 38–44. DOI: 10.4103/apc.APC_146_17
- Vijarnsorn C, Durongpisitkul K, Chungsomprasong P, et al. Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts. PLoS One. 2018; 13(4): 1–18. DOI: 10.1371/journal.pone.0195092
- Kumar RK, Viswanathan S. Hemodynamic assessment of congenital heart defects with left to right shunts and pulmonary hypertension. J Indian Coll Cardiol [Internet]. 2011; 1(1): 28–35. DOI: 10.1016/S1561-8811(11)80015-5
- Bhalgat PS, Pinto R, Dalvi BV. Transcatheter closure of large patent ductus arteriosus with severe pulmonary arterial hypertension: Short- and intermediate-term results. Ann Pediatr Cardiol. 2012; 5(2): 135–40. DOI: 10.4103/0974-2069.99614
- Feng J, Kong X, Sheng Y, Yang R. Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure. Ther Clin Risk Manag. 2016; 12: 1609–13. DOI: 10.2147/TCRM.S112400
- Charisopoulou D, Bini RM, Riley G, Janagarajan K, Moledina S, Marek J. Repair of isolated atrial septal defect in infants less than 12 months improves symptoms of chronic lung disease or shunt-related pulmonary hypertension. Cardiol Young. 2020. DOI: 10.1017/S1047951120000463
- Van Loon RLE, Roofthooft MTR, Hillege HL, et al. Pediatric pulmonary hypertension in the Netherlands: Epidemiology and characterization during the period 1991 to 2005. Circulation. 2011; 124(16): 1755–64. DOI: 10.1161/CIRCULATIONAHA.110.969584
- Murni IK, Musa NL. The need for specialized pediatric cardiac critical care training program in limited resource settings. Front Pediatr. 2018; 6(March): 1–5. DOI: 10.3389/fped.2018.00059
- Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galiè N. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: A comparison between clinical subgroups. Eur Heart J. 2014; 35(11): 716–24. DOI: 10.1093/eurheartj/eht072
- Xi SB, Wang SS, Qian MY, et al. Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease. Chin Med J (Engl). 2019; 132(7): 811–8. DOI: 10.1097/CM9.0000000000000145
- Barst RJ, Ivy DD, Foreman AJ, McGoon MD, Rosenzweig EB. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Am J Cardiol [Internet]. 2014; 113(1): 147–55. DOI: 10.1016/j.amjcard.2013.09.032
- Thomaz AM, Kajita LJ, Aiello VD, et al. Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments. Pulm Circ. 2019; 9(3): 1–13. DOI: 10.1177/2045894019837885
- Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 SUPPL.). DOI: 10.1016/j.jacc.2013.10.029
- Ranard LS, Mallah WEl, Awerbach JD, et al. Impact of Pulmonary Hypertension on Survival Following Device Closure of Atrial Septal Defects. Am J Cardiol [Internet]. 2019; 124(9): 1460–4. DOI: 10.1016/j.amjcard.2019.07.042
- Barst RJ, Chung L, Zamanian RT, Turner M, McGoon MD. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL registry. Chest [Internet]. 2013; 144(1): 160–8. DOI: 10.1378/chest.12-2417
- Wang LY, Lee KT, Lin CP, et al. Long-term survival of patients with pulmonary arterial hypertension at a single center in Taiwan. Acta Cardiol Sin. 2017; 33(5): 498–509.
- Lammers AE, Adatia I, Del Cerro MJ, et al. Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011. Pulm Circ. 2011; 1(2): 280–5. DOI: 10.4103/2045-8932.83445
- Ryan JJ, Huston J, Kutty S, et al. Right Ventricular Adaptation and Failure in Pulmonary Arterial Hypertension. Can J Cardiol. 2015; 31(4): 391–406. DOI: 10.1016/j.cjca.2015.01.023
- Lindberg L, Olsson AK, Jögi P, Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg. 2002; 123(6): 1155–63. DOI: 10.1067/mtc.2002.121497
- Brunner N, de Jesus Perez VA, Richter A, et al. Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery. Pulm Circ. 2014; 4(1): 10–24. DOI: 10.1086/674885
- Macrae DJ, Field D, Mercier JC, et al. Inhaled nitric oxide therapy in neonates and children: Reaching a European consensus. Intensive Care Med. 2004; 30(3): 372–80. DOI: 10.1007/s00134-003-2122-3
- Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev. 2014; 2014(7). DOI: 10.1002/14651858.CD005055.pub3
- Majure DT, Greco T, Greco M, et al. Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery: An update. J Cardiothorac Vasc Anesth [Internet]. 2013; 27(2): 220–9. DOI: 10.1053/j.jvca.2012.08.005
- Trachte AL, Lobato EB, Urdaneta F, et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg. 2005; 79(1): 194–7. DOI: 10.1016/j.athoracsur.2004.06.086
- Kwan WC, Shavelle DM, Laughrun DR. Pulmonary vascular resistance index: Getting the units right and why it matters. Clin Cardiol. 2019; 42(3): 334–8. DOI: 10.1002/clc.23151
DOI: https://doi.org/10.5334/gh.831 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 27, 2020
Accepted on: Mar 24, 2021
Published on: Apr 21, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2021 Nadya Arafuri, Indah K. Murni, Nikmah S. Idris, Cuno S. P. M. Uiterwaal, Ary I. Savitri, Sasmito Nugroho, Noormanto Noormanto, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.